GlobeNewswire

NRT Acquires NCC, Leading Provider of Next Generation Credit Marker and AML Information Services to Global Gaming Operators

Dela

NCC is a strong addition to the NRT family of businesses, enabling the company to fortify a leading position in casino credit platforms and further enhancing NRT's value proposition by providing casino operators opportunities to grow revenue, reduce risk, meet compliance regulations, and better serve their VIP guests.

LAS VEGAS, April  11, 2018  (GLOBE NEWSWIRE) -- NRT Technology Corp. ("NRT"), a global technology leader of current and next generation payment systems, specialized financial/marketing self-serve kiosks, and digital and mobile experiences, announced that it has acquired the assets of privately held National Cred-A-Chek, Inc. ("NCC")  the leading provider of information services for underwriting credit markers to more than 300 casino operators around the world. Terms of the agreement were not disclosed.

The NCC acquisition follows closely on the heels of NRT's recently announced eMarker® acquisition, a solution which uses mobile technology and digital signatures to eliminate the cumbersome process of managing paper-issued casino markers, thereby expediting the marker process for casinos and their patrons.

NCC is a versatile and essential source of data on which casinos rely to make informed decisions regarding the underwriting of credit markers for their guests. By leveraging this powerful FCRA-compliant (Fair Credit Reporting Act) cloud-based platform in conjunction with eMarker®, NRT will become the first and only end-to-end solution for credit application hosting, bank verification data, gaming credit history data, third-party credit bureau data, ID validation, AML compliance, issuance, processing, storage, redemption, and repayment of casino markers.

"NCC is a great company with a long and successful history of using data and technology to deliver unparalleled insight into casino guests and their credit worthiness," said Christine Landis, President of NCC. "Our service goes back 40 years, and it has been a privilege to carry on Diane Hunt's legacy. Now is the right time to pass it off to a forward-thinking management team that can leverage our global operating model and technology platform."

"This acquisition opens an exciting opportunity and is a strong fit for NRT.  It reinforces our strategic focus to be a leading global casino information and data analytics solutions provider," said John Dominelli, NRT's Founder and President. "We're delighted to count on the expertise of NCC's management and staff, and we welcome them into the NRT family."

NRT's recent investment in Gaming Analytics.AI will further set the stage for the next evolution of technology enhancements for the gaming industry, allowing NRT to incorporate AI search-driven analytics with insights and contexts of marker player behavior and preferences.

"NCC and eMarker together create a groundbreaking end-to-end marker underwriting and issuance solution for casinos," said Kirk Sanford, Sightline Payments Founder and CEO. "Through NCC, we will have a robust platform connected to hundreds of casinos from which to offer advanced data analytics services for underwriting processes and 'next generation' risk scoring information."

Mrs. Landis added, "Our immediate objective is consistency and continuity for our customers and the NCC team members. I will stay on through a transition period to bring all the benefits of the combined companies together as quickly as possible while ensuring that NCC's solutions remain as nimble and well-organized as ever, and to efficiently incorporate more capabilities to accelerate performance for our valued customers."

About NCC

For the past 40 years, NCC's mission has been to help our over 300 casino partners around the world to optimize risk-based decisions for underwriting of casino credit and to meet AML compliance requirements. Our FCRA-compliant cloud-based platform automates marker credit applications and consolidates multidimensional reports of casino marker, front money, and check cashing information, bank verification data, as well as third-party credit bureau, identity validation, and KYC tools.

About NRT & Sightline

On closing of the pending merger, NRT Sightline will be the global leader in the design and development of enterprise platforms for the gaming industry, including current and next generation payment systems, specialized self-serve financial/marketing kiosks, big data analytics utilizing artificial intelligence and gamification, credit marker information services, and digital and mobile experiences. Through our global family of companies, we enable more than 1 billion physical and digital commerce experiences at over 750 casino properties worldwide, including the top 25 largest casino corporations.  By seamlessly combining technological innovation with strategic partnerships, our companies create the most convenient, reliable, and secure omni-channel payment ecosystem for casino operators and their guests. NRT and Sightline have been recognized with numerous industry awards, including the coveted "Most Innovative Gaming Technology Product of the Year" for our Play+(TM) cloud-based cashless funding platform. Our collective solutions are used by casinos, lotteries, race and sports, banking & retailers around the world.

For further information about this acquisition, please contact:  Michael Dominelli, NRT's SVP Marketing mdominelli@nrttech.com

For more information about Sightline or its pending merger with NRT, please contact:  Omer Sattar, Sightline's EVP Strategic Relationships osattar@sightlinepayments.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NRT Sightline via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum